Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Articles
February 1, 2025
HTL Biotechnology at IMCAS 2025
Our innovative portfolio — from 𝐇𝐲𝐚𝐥𝐮𝐫𝐨𝐧𝐢𝐜 𝐀𝐜𝐢𝐝 to 𝐏𝐨𝐥𝐲𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞𝐬, 𝐍𝐞𝐮𝐫𝐨𝐦𝐨𝐝𝐮𝐥𝐚𝐭𝐨𝐫𝐬, and 𝐇𝐮𝐦𝐚𝐧 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐂𝐨𝐥𝐥𝐚𝐠𝐞𝐧 — drew significant interest.
Our products were highlighted in 𝐬𝐲𝐦𝐩𝐨𝐬𝐢𝐚, on our clients’ booths, and in expert discussions. It was inspiring to see industry leaders recognize the quality and innovation behind HTL Inside.
Thank you to everyone who came to our booth and engaged discussions with our team!
Feel the difference with HTL Inside.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles April 2, 2025François Fournier Featured in Korean Press
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
-
Articles March 28, 2025HTL Biotechnology at AMWC Monaco 2025
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
-
Articles March 11, 2025HTL Biotechnology at CIBE China
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.